Is SBRT Boost Feasible for PET Positive Lymph Nodes for Cervical Cancer? Evaluation using Tumor Control Probability and QUANTEC Criteria

医学 宫颈癌 核医学 颈淋巴结 淋巴 放射科 医学物理学 癌症 内科学 病理 转移
作者
J. E. Snyder,A. Willett,Wenqing Sun,Yusung Kim
出处
期刊:Practical radiation oncology [Elsevier]
卷期号:9 (2): e156-e163 被引量:5
标识
DOI:10.1016/j.prro.2018.10.012
摘要

This study aimed to examine the feasibility of stereotactic body radiation therapy (SBRT) as an external beam radiation therapy boost to positron emission tomography (PET) positive lymph nodes (LN) in patients with cervical cancer and to evaluate overall tumor control probability (TCP) increase.Ten patients with cervical cancer and PET positive LN metastasis who received external beam radiation therapy (45 Gy), followed by a 3-dimensional conformal radiation therapy boost (5.4-9 Gy) and tandem-and-ovoid high-dose-rate brachytherapy (16-30 Gy) were retrospectively enrolled in this study. SBRT plans were generated using 21 Gy, 24 Gy, or 30 Gy as a replacement for 3-dimensional conformal radiation therapy boost. The 2 Gy-per-fraction equivalent dose maps were made using an α/β value of 10 for PET positive LNs and 3 for organs at risk (OARs). TCP values were calculated using a logistic TCP model, where 2 input parameters (D50 and Gamma50 = 2) were modeled by 2 clinical outcomes: our institution and the literature. OAR sparing was evaluated using Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC) dose limits.Thirty percent of 10 patients receiving conventional boost experienced recurrence. The TCP of the SBRT schemes was 88% ± 7% (97% ± 2%; 21 Gy), 96% ± 1% (99% ± 0%; 24 Gy), and 99% ± 1% (100% ± 0%; 30 Gy), and the conventional LN-boost TCP value was 25% ± 11% (58% ± 15%) when TCP input parameters were based on published clinical outcome data for LN SBRT treatments (institutional outcome data). The tumor coverage doses (D90) of the SBRT boost plans were on average 32.34 Gyαβ=10 (21 Gy), 37.78 Gyαβ=10 (24 Gy), and 55.54Gyαβ=10 (30 Gy) higher than the conventional LN boost plan. The QUANTEC OAR dose constraints were met for the bladder, rectum, and bowel in all cases for the SBRT LN 21 Gy group, and in 90% and 70% of cases in the SBRT LN 24 Gy and SBRT LN 30 Gy groups, respectively.An SBRT boost dose of 30 Gy can be delivered without compromising QUANTEC OAR limits. The use of SBRT increases TCP values, regardless of the input parameters.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
可宝想当富婆完成签到 ,获得积分10
1秒前
高高的蓝天完成签到,获得积分10
1秒前
无物完成签到,获得积分10
1秒前
bingo发布了新的文献求助10
1秒前
朴素小鸟胃完成签到,获得积分10
1秒前
LAIII完成签到,获得积分10
1秒前
乐观的皮卡丘完成签到,获得积分10
2秒前
zsj发布了新的文献求助10
2秒前
武巧运完成签到 ,获得积分10
2秒前
Swagger发布了新的文献求助10
3秒前
Ttttt应助hhluck采纳,获得10
3秒前
3秒前
杨一乐发布了新的文献求助10
3秒前
小肥侠完成签到,获得积分10
3秒前
4秒前
4秒前
慕辰完成签到 ,获得积分10
5秒前
小蘑菇应助朴素小鸟胃采纳,获得30
5秒前
圆圆完成签到 ,获得积分10
5秒前
WU完成签到,获得积分10
5秒前
5秒前
顺利一江完成签到 ,获得积分10
6秒前
6秒前
Orange应助聪慧凡雁采纳,获得10
6秒前
yan完成签到,获得积分10
6秒前
6秒前
7秒前
7秒前
8秒前
赘婿应助活力半蕾采纳,获得10
8秒前
烟花应助清秀寇采纳,获得10
8秒前
冷静橘子完成签到,获得积分10
8秒前
Ava应助LFY采纳,获得10
8秒前
尼古拉斯佩奇完成签到,获得积分10
8秒前
von完成签到,获得积分10
8秒前
9秒前
陆木子发布了新的文献求助100
10秒前
10秒前
淘宝叮咚发布了新的文献求助10
10秒前
共享精神应助dsw采纳,获得10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Encyclopedia of Reproduction Third Edition 3000
《药学类医疗服务价格项目立项指南(征求意见稿)》 1000
花の香りの秘密―遺伝子情報から機能性まで 800
1st Edition Sports Rehabilitation and Training Multidisciplinary Perspectives By Richard Moss, Adam Gledhill 600
Chemistry and Biochemistry: Research Progress Vol. 7 430
Biotechnology Engineering 400
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5629294
求助须知:如何正确求助?哪些是违规求助? 4719943
关于积分的说明 14969087
捐赠科研通 4787406
什么是DOI,文献DOI怎么找? 2556301
邀请新用户注册赠送积分活动 1517428
关于科研通互助平台的介绍 1478125